drug · protein
patient view →survodutide
Phase 3updated 2mo agoby Boehringer Ingelheim International GmbH🔗 ChEMBL
Phase 3community read0 votes
Protein drug with a maximum clinical stage of Phase 3 (across all indications), with 5 investigational indications.
targets
Glucagon-like peptide 1 receptorGlucagon receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that